PLEASANTON, Calif., June 5, 2017 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for the cobas® CMV (cytomegalovirus) test for use on the fully ...
- CMV is the most common and serious viral infection in transplant patients - The cobas® CMV test provides reliable, reproducible, high-quality results for clinical decision-making - CMV viral load ...
The state of New York plans to add testing for Cytomegalovirus, known as CMV, to its Newborn Screening Program beginning this fall. WSHU’s Madi Steddick spoke with Dr. Sharon Nachman, the division ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results